Fermenta Biotech has updated its schedule for a one-to-one physical meeting with investors, moving the event from October 5 to October 7, 2026, in Mumbai. The company confirmed that no unpublished price-sensitive information (UPSI) will be discussed during this interaction.

The engagement remains part of Fermenta Biotech’s ongoing efforts to maintain regular communication with its investor base. Officials from the company will participate in the session, which is scheduled to take place at a location in Mumbai. This update supersedes the earlier intimation regarding the September 24 date, the subsequent September 29 date, and the interim October 5 date.

The company noted that relevant press releases and investor presentations available on its website and stock exchange portals may be discussed during the interaction. Fermenta Biotech emphasized that changes to the schedule may occur due to exigencies on the part of the company or investors.

This disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The revised intimation was issued by Varadvinayak Khambete, Company Secretary and Head – Legal, on October 1, 2026.

Fermenta Biotech promoter Preeti Thakkar sold 11,65,938 equity shares, representing 3.96% of the company's share capital, in the open market on September 28, 2026.

The transaction was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Following the sale, her total holding in the company has decreased from 7.61% to 3.65%.

Shareholding details

The disclosure form indicates that the sale was executed entirely through the open market mechanism. There were no encumbrances, warrants, or convertible securities involved in the transaction prior to or after the sale. The total diluted share capital of the company remained unchanged at ₹14,71,54,935, divided into 2,94,30,987 equity shares of ₹5 each.

Regulatory compliance

The intimation was filed with the BSE and National Stock Exchange on September 29, 2026. The company secretary and head of legal, Varadvinayak Khambete, signed off on the disclosure to the exchanges. The promoter confirmed the trade details in a separate letter to the company's compliance officer, citing the same date and volume for the open market sale.